It represents the most common cancer in children younger than 1 year [2] and is a heterogeneous disease that may either have a very good prognosis (e.g., stage 4S neuroblastoma) or a dismal outlook (e.g., MYCN-amplified neuroblastoma) [1]. The gene discussed is MYCN; the disease is neuroblastoma.